Pharmacogenetics, Therapies and Trials

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Pharmacogenetics

Therapies

Trials

A personal touch: the role of bioprinting in drug discovery

Drug Discovery World

OCTOBER 5, 2022

The company hopes that through its technology, academics, life science industries and pharma industries can test and develop more personalised treatments for intricate tissue engineering and cell therapy, such as repairing damaged tissue, replacing lost biological functions, localised therapeutic solutions and complex drug formulations. .

Pharmacogenetics

Pharmacogenetics Regulations Drugs Therapies

CNS distribution of panobinostat in preclinical models to guide dosing for pediatric brain tumors [Metabolism, Transport, and Pharmacogenetics]

ASPET

OCTOBER 12, 2023

With this in mind, a major challenge in developing therapies for central nervous system (CNS) tumors is to overcome barriers to delivery, including the blood-brain barrier (BBB). Achieving adequate exposure of a therapeutic agent at the target is a critical determinant of efficacious chemotherapy.

Pharmacogenetics

Pharmacogenetics Clinical Trials Treatment Therapies

Drug Discovery Digest

A personal touch: the role of bioprinting in drug discovery

CNS distribution of panobinostat in preclinical models to guide dosing for pediatric brain tumors [Metabolism, Transport, and Pharmacogenetics]

Stay Connected